Free and total plasma concentrations of phenytoin (PHT) and carbamazep
ine (CBZ) and its active metabolite carbamazepine-10,11-epoxide (CBZ-E
) were determined in a prospective study of 86 pregnant epileptic wome
n. The pharmacokinetics of PHT and CBZ during the three trimesters wer
e compared with kinetics at least 10 weeks postpartum. Plasma clearanc
e and unbound CBZ clearance were slightly decreased during the last tr
imester. Total and free plasma CBZ-E concentrations did not change sig
nificantly during pregnancy. Plasma PHT clearance, on the other hand,
increased from the first trimester. A less pronounced increase was obs
erved for clearance of unbound PHT; the increase was statistically sig
nificant only during the third trimester.